I nterleukin 12 is a heterodimeric cytokine consisting of p35 and p40 subunits that is secreted by APCs such as dendritic cells and macrophages, neutrophils, and possibly by B lymphocytes (1) . Infection with intracellular pathogens induces the synthesis of IL-12 and IL-12 production can also be stimulated by engagement of the CD40 Ag on the APC by the CD40 ligand expressed on activated T cells (2, 3) . IL-12 promotes IFN-␥ production by NK cells and is the major cytokine responsible for driving Th1 development in response to protein Ags. The effects of IL-12 are mediated through a heterodimeric receptor complex consisting of the ␤1 and ␤2 receptor subunits (1) . The ␤1 subunit is expressed on resting T cells, whereas expression of the ␤2 subunit is up-regulated during the process of T cell activation (4) . Upon high affinity binding of IL-12 by its receptor, the associated kinases, Jak2 and Tyk2, become phosphorylated and in turn phosphorylate critical tyrosine residues within the cytoplasmic domains of both the ␤1 and ␤2 receptor subunits (5) . Tyrosine phosphorylation of the receptor tails recruits Stat4. Stat4 becomes phosphorylated by the associated JAK kinases and subsequently forms homodimers that translocate to the nucleus and function as transcriptional activators by binding to specific DNA response elements in the promoter regions of IL-12 inducible genes (6) . Stat1, Stat3, and Stat5 may also be capable of mediating some responses induced by IL-12 (7) .
The critical role of IL-12 in Th1 development has been demonstrated by studies of IL-12 deficient (Ϫ/Ϫ), IL-12R␤1 Ϫ/Ϫ , and Stat4 Ϫ/Ϫ mice (8 -10) . Mutations in cytokine signaling pathways in humans have provided important additional insights into the role played by specific signaling proteins in the activation of lymphocytes (11) . Children with spontaneous mutations in the IL-12 p40 subunit that result in the inability to secrete the biologically active p70 heterodimer have impaired Ag-driven IFN-␥ production that could be reconstituted by the addition of exogenous recombinant IL-12 (12, 13) . Children with mutations in the IL-12R␤1 gene that results in the inability to express the receptor on the cell surface also have defective in vitro Ag-driven IFN-␥ production, but production could not be augmented by exogenous IL-12. Both of these deficiencies are characterized clinically by recurrent disseminated BCG infection after neonatal immunization, infections with nontuberculous mycobacteria, and invasive Salmonella infections, the majority due to nontyphi Salmonella species (14) .
In this report and the accompanying paper (15), we characterize a defect in the IL-12-signaling pathway in both NK cells and activated T cells that was detected in the subline of B10.Q (B10.Q-H2 q /SgJ, which will be referred to as B10.Q/J) mice maintained at The Jackson Laboratory (Bar Harbor, ME). Although the expression of both IL-12R subunits on activated T cells was normal, stimulation with IL-12 failed to induce phosphorylation of Stat4. Because Stat4 gene function in these mice appears to be normal (15), B10.Q/J mice appear to have a novel defect in the IL-12 signal transduction cascade that is localized between receptor binding and activation of Stat4.
Materials and Methods

Mice
B10.Q-H2q/SgJ (B10.Q/J) and C57BL10/J mice were obtained from The Jackson Laboratory. B10.Q/Ai mice were obtained from Taconic Farms (Tarrytown, NY). All mice were housed under specific-pathogen-free conditions. Males between the ages of 8 and 12 wk were used exclusively.
CD3, anti-mouse CD4, anti-mouse CD8, and anti-mouse NK1.1 were purchased from PharMingen (San Diego, CA).
Abs to the ␤1-and ␤2-chains of murine IL-12R were the kind gift of Drs. Chang-you Wu (National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD) and Rolf Erhardt (Bioseek, Burlingame, CA), respectively. Isotype controls were obtained from PharMingen. Rabbit anti-mouse Stat4 was purchased from Santa Cruz Biotechnologies (Santa Cruz, CA) and rabbit anti-phospho-specific Stat4 was from Zymed (South San Francisco, CA). Peroxidase-conjugated anti-rabbit Ab was from Boehringer Mannheim (Indianapolis, IN).
FACS analysis
Cells (1-2 ϫ 10 6 ) were resuspended in PBS and placed in individual wells of a 96-well V-bottom Costar plate. Cells were then pelleted by a brief spin at 1400 rpm and 4°C for 2 min. Cells were then incubated with either 1 g normal hamster IgG or 1 g hamster anti-murine IL-12R␤1 or hamster anti-mouse IL-12R␤2 diluted in PBS containing 5% BSA. Cells were incubated with the respective Ab for 20 min at 4°C and then washed twice with PBS. The cells were then incubated in PBS-normal mouse serum for 10 min before the addition of 2 g streptavidin-PE-biotinylated goat antihamster IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) diluted in PBS-BSA. Cells were subsequently washed twice in PBS and resuspended in streptavidin-PE (PharMingen) diluted in PBS. After a 10-min incubation at 4°C, FITC-labeled anti-CD4 or anti-CD8 (PharMingen) was added directly to wells for an additional 20 min incubation at 4°C. Cells were again washed twice in PBS and resuspended in PBS. 7-Amino actinomycin D was added immediately before FACS analysis to exclude dead cells from analysis. Analysis was performed using CellQuest software (Becton Dickinson, San Diego, CA).
Immunization and disease induction
Mice were immunized with an emulsion of type II collagen in CFA as described previously (16) , and animals were scored for disease beginning on day 7. Serum was obtained by retroorbital sinus puncture 21 days after immunization and isotype-specific ELISAs for type II collagen-specific Abs were performed as previously described (16) .
Cell culture
For testing Ag-specific responses, draining lymph node (LN) 2 cells (3) were harvested 10 -14 days after immunization and processed as previously described (16) . In brief, cells (4 ϫ 10 6 /ml) were cultured in RPMI 1640 containing 10% FCS and standard supplements (cRPMI) in the presence of either purified protein derivative (PPD) (10 g/ml) or medium alone. To assess global T cell responsiveness, spleen cells from naive animals were prepared and cultured as above, except soluble anti-CD3⑀ (1 g/ml) or the combination of PMA (5 ng/ml) and ionomycin (300 ng/ml) were used. Supernatants were obtained at 48 h and frozen at Ϫ70°C until used. To assess the immune response to exogenous cytokine administration, spleen cells from naive animals were prepared as above and cultured in the presence of IL-2 (10 ng/ml), IL-12 (10 ng/ml), IL-18 (10 ng/ml), various combinations of these cytokines, or medium alone. Supernatants were harvested at 24, 48, and 72 h and frozen at Ϫ70°C until used. In some experiments, CD4 ϩ T cells were purified from spleens by positive selection with magnetic anti-CD4 Microbeads (Miltenyi Biotec, Auburn, CA), and CD4 ϩ T cells were isolated using an autoMACS magnetic cell separator. After positive selection of CD4 ϩ T cells, the negative fraction (CD4 Ϫ ) was irradiated (3000R) and used as APC. CD4 ϩ T cells (2 ϫ 10 6 /ml) were combined with the irradiated negative fraction (2 ϫ 10 6 /ml) and cultured with 2.5 g/ml Con A for 72 h. The cells were then harvested and cultured ( ϩ cells were also tested for their capacity to secrete IFN-␥ as described above for unseparated spleen cells.
ELISA
IFN-␥ ELISA kits were purchased from PharMingen, and supernatants from previously mentioned experiments were assessed for IFN-␥ according to the manufacturer's recommendations.
EMSA
EMSA were performed essentially as reported previously (6) . Naive splenocytes were cultured for 48 h in the presence of soluble anti-CD3⑀ (1 g/ml) with or without the addition of exogenous recombinant IL-12 (10 ng/ml). Cells were harvested, washed extensively with PBS, and cultured in serum-free cRPMI 1640 for 4 h. Subsequently, 5 ϫ 10 6 cells were cultured in 1 ml cRPMI in the presence of IL-2 (100 ng/ml), IL-12 (50 ng/ml), or medium alone for 20 min. Each culture was then washed with 10 ml ice-cold PBS/100 M sodium vanadate. Cell pellets were then resuspended in 20 -40 l lysis buffer (0.5% Nonidet P-40, 50 mM Tris (pH 8.0), 10% glycerol, 100 M EDTA (pH 8.0), 50 mM NaF, 150 mM NaCl, 100 M Na 3 VO 4 , 1 mM DTT, 400 M PMSF, 1 g/ml pepstatin A, 1 g/ml leupeptin, 1 g/ml aprotinin) and incubated on ice for 60 min with frequent vortexing. Lysates were centrifuged at 15,000 rpm for 15 min at 4°C. Supernatants were harvested and stored at Ϫ70°C. Protein concentrations were determined using the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA) with BSA as standard. For assays, 25 g of cell lysate were incubated with 100 ng 32 P-labeled oligonucleotide in reaction buffer (40 mM KCl, 1 mM MgCl 2 , 0.1 mM EDTA, O.5 mM DTT, 20 mM HEPES (pH 7.9), 6% glycerol, 1 mg/ml BSA, 0.1 mg/ml poly(dI-dC)) for 15 min at room temperature. Reactants were separated by electrophoresis on a 4.5% polyacrylamide gel buffered with 0.22ϫ Tris-buffered EDTA. Gels were dried and exposed directly to Kodak Biomax MR film (Sigma). To generate a Stat4-binding DNA element, a double-stranded oligonucleotide corresponding to an IFN-␥ activation site (GAS)-like element found in the mouse Fc␥R1 promoter (5Ј-gatcGCATGTTTCAAGGATTTGAGATG TATTTCCACAGAAAAGG) was synthesized with a 5Ј-GATC overhang on each end (denoted by lower case letters) and labeled with [ 32 P]dCTP using Klenow DNA polymerase by standard techniques (17) . For generation of an IL-2-responsive Stat5-binding element, the GAS-like binding element in the CD23 promoter region (5Ј-gatcAAGACCTTTCTAA GAACTTTAATCT) was constructed using similar techniques.
Immunoblotting
Spleen cells were cultured in cRPMI and Con A, 2.5 g/ml, for 48 h. As a positive control, the IL-12-responsive NK3.3 cells (a gift of Dr. J. Kornbluth, Arkansas Cancer Research Center, Little Rock, AR) was grown in RPMI with 15% FCS further supplemented with 10% Lymphocult-T (Biotest Diagnostics, Denville, NJ) and 10 ng/ml human IL-2. Cells were washed in acidified RPMI (pH 6.4) and rested overnight in RPMI 1640 medium with 1%FCS-1% BSA. Cells were then washed and stimulated (50 ϫ 10 6 cells/ml) for 5 or 15 min in the presence of 20 ng/ml IL-12. For some experiments, cells were stimulated for up to 50 min in the presence of 50 ng/ml IL-12.
Cell lysis in 1% Triton X-100 buffer, SDS-PAGE resolution, and subsequent immunoblotting were performed essentially as described (6) . For immunoblotting with anti-Stat Abs, membranes were blocked in Trisbuffered saline containing 0.05% Tween 20 and 5% nonfat dried milk and incubated sequentially with phospho-specific anti-Stat4 (1 g/ml) followed by HRP-conjugated goat anti-rabbit IgG (1:8000). Detection was performed using enhanced chemiluminescence. Membranes were stripped using conventional methods and reprobed with anti-Stat4 to confirm equal loading of lanes.
Results
B10.QJ mice manifest a severely deficient Th1 immune response
During the course of experiments on cytokine-mediated regulation of collagen-induced arthritis (CIA (16)), we compared the susceptibility of two sublines of B10.Q mice that bear the permissive H-2 q MHC haplotype. Surprisingly, mice purchased from The Jackson Laboratory (B10.Q/J) were resistant to the induction of CIA when immunized with heterologous type II collagen, whereas B10.Q/Ai mice, which had been bred at Taconic Farms, developed a severe inflammatory polyarthritis (Fig. 1A) . B10.Q/J mice also had a blunted humoral response to collagen with defects in the production of both the IgG2a and IgG1 fraction of type II collagenspecific Abs (Fig. 1B) .
Because immunization with Ag in CFA usually results in a predominantly Th1-mediated response characterized by IFN-␥ production, we next assessed the ability of these mice to produce IFN-␥ in response to nominal Ag. Cells were obtained from draining LN 14 days after immunization and cultured for 48 h in the presence of PPD. LN cells from B10.Q/J mice failed to produce IFN-␥ in response to PPD, whereas cells from B10.Q/Ai strain produced significant amounts of IFN-␥ (Fig. 2A) . Similar defects in Ag-specific IFN-␥ production were observed when the two strains were immunized with OVA in CFA and restimulated in vitro with OVA (data not shown). We have not specifically tested the responses of cells from the two strains to collagen, because we have had great difficulty measuring collagen-specific IFN-␥ production even when cells from mice with severe disease were tested. In any case, the defect in generating an Ag-specific IFN-␥ response in B10.Q/J mice did not appear to be Ag specific. Because IFN-␥-deficient mice have an enhanced susceptibility to CIA (16) , the failure to generate disease and a Th1 response is mostly likely secondary to defects in the ability to produce or respond to cytokines (IL-12, IL-18) that play important roles in the generation of IFN-␥-producing Th1 cells. The latter explanation appears likely given that naive splenocytes from both of these strains produced similar amounts of IFN-␥ when stimulated with a high concentration of soluble anti-CD3 or the combination of PMA and ionomycin (Fig. 2B) . The capacity of both of these stimuli to induce IFN-␥ production is IL-12/IL-18 independent under these conditions (R. Orlmann and E. M. Shevach, unpublished observations).
Splenocytes from B10.Q/J mice respond poorly to IL-12
Because the experiments described above were designed to measure IFN-␥ production by T cells, it was also of interest to determine whether NK cells from the B10.Q/J would be capable of producing IFN-␥ when stimulated with IL-12 alone. Single-cell suspensions of splenocytes from naive animals of several different strains were cultured with increasing concentrations of IL-12 for 24 h, and IFN-␥ production was evaluated by ELISA. As seen in Fig. 3 , splenocytes from B10.Q/J animals responded very poorly when compared with all other strains tested. To further characterize the cell type producing IFN-␥ in response to IL-12, T cells were depleted from the spleen cell preparation, and the resultant population similarly stimulated, with nearly identical results (Fig.  3) . This suggests that the NK cell population in B10.Q/J mice, the primary source of IFN-␥ in response to IL-12 in naive animals, is defective in its capacity to respond appropriately to stimulation with exogenous IL-12.
The impaired IFN-␥ response to IL-12 by NK cells from B10.Q/ J mice is partially corrected by the addition of exogenous IL-18
Because IL-18 alone has been reported to induce IFN-␥ production by NK cells (18) , splenocytes from both of the strains were stimulated with IL-2, IL-12, IL-18, and combinations of these cytokines to determine whether the IFN-␥ response to IL-12 could be normalized. Splenocytes from B10.Q/Ai mice produced low levels of IFN-␥ when stimulated with IL-12 or IL-18 alone, but manifested a robust response to combinations of IL-2 and IL-12, IL-2 and IL-18, and IL-12 and IL-18 at both the 24-h and 72-h time points. No IFN-␥ production could be detected when cells from the B10.Q/J mice were stimulated with all the cytokine combinations at 24 h (Fig. 4A) , but low levels of IFN-␥ were observed after 72 h stimulation with IL-2/IL-12, and substantial levels of IFN-␥ were seen in response to the combination of IL-12 and IL-18 (Fig. 4B) .
The capacity of T cells from B10.Q/J mice to respond to IL-12 is impaired even in the presence of IL-18
Because the studies with naive splenocytes strongly suggested that NK cells from B10.Q mice manifest a partial defect in IL-12 responsiveness, we next evaluated whether CD4 ϩ T cells from this strain had a similar defect. Because resting T cells do not express the IL-12R␤2-chain and do not respond to IL-12 alone, we activated CD4 ϩ T cells from both strains with Con A. The blast cells were extensively washed and then cultured in IL-2, IL-12, IL-18, FIGURE 1. B10.Q mice mount a poor immune response to immunization with heterologous type II collagen. A, B10.Q/Ai and B10.Q/J mice were immunized with collagen in CFA and scored for disease (16) . The results are the mean of the disease scores of 10 animals of each strain. Sera obtained from mice immunized 21 days previously were pooled, and the levels of anti-type II collagen IgG1 (B) and IgG2a (C) were determined by ELISA.
and IL-12/IL-18. Con A blasts from B10.Q/Ai mice produced IFN-␥ when stimulated with IL-12, IL-18, or the combination, whereas blasts cells from the B10.Q/J mice were unresponsive (Fig. 5A) . In addition to inducing the production of IFN-␥, IL-12 is capable of inducing a proliferative signal to activated T cells. CD4 ϩ blasts obtained from B10.Q/Ai mice demonstrated a strong proliferative response (Fig. 5B, bottom) to IL-12, but not IL-18. The addition of IL-18 did not lead to enhancement of the proliferative response induced by IL-12. In contrast, blasts cells from B10.Q/J mice reproducibly demonstrated a higher basal level of proliferation to medium alone, and only slight enhancement of this response was seen when cytokines were added (Fig. 5B, top) .
Expression of the IL-12R on T and NK cells from B10.Q/J mice is normal
The failure of cells from B10.Q/J mice to respond to IL-12 could be secondary to a defect in the expression of the IL-12R. The recent production of mAbs to the ␤1-and ␤2-chains of the mouse IL-12R complex has facilitated analysis of the cell surface expression of this receptor (19) . The ␤1-chain is expressed at low levels on resting CD4 ϩ T lymphocytes and is up-regulated on T cell activation (1). The IL-12R␤1-chain was expressed on a slightly lower percentage (marked area, 15% vs 24%) and at a lower level on CD4 ϩ T cells from B10.Q/J mice than on CD4 ϩ T cells from normal C57BL/10 mice (Fig. 6 ). After stimulation with Con A, the levels of expression of the IL-12R␤1-chain were indistinguishable on CD4 ϩ and CD8 ϩ T cells from the two strains (Fig. 7) . The IL-12R␤2-chain was not expressed on resting CD4 ϩ or CD8 ϩ T cells from either strain (data not shown) but was up-regulated to the same extent after stimulation with Con A (Fig. 7) . Thus, both chains of the IL-12R on cells from B10.Q mice appear to be transcribed normally and expressed on the cell surface of CD4 ϩ T cells.
Because NK cells are the primary source of IFN-␥ in response to IL-12 in naive splenocyte populations, we examined the level of IL-12R␤2-chain expression that is constitutively expressed on unstimulated NK cells. NK cells from B10.Q and C57BL10/J mice expressed similar levels of the IL-12R ␤1-and ␤2-chains (Fig. 6 ). Thus, a defect in the expression of the IL-12R does not appear to account for the nonresponsiveness of either T or NK cells from the B10.Q/J mice to IL-12.
B10.Q/J mice do not signal normally through the IL-12R
Signaling through the IL-12R is thought to involve ligand binding to the ␤1-chain, heterodimerization with the ␤2-chain, and subsequent phosphorylation of two receptor-associated Janus kinases, Tyk2 and Jak2 (5). These phosphorylated intermediates recruit Stat4 to the complex (6). Stat4 is then itself phosphorylated, homodimerizes, and then is transported to the nucleus where it regulates transcription of a number of genes.
Because the IL-12R is expressed normally on activated T cells from B10.Q/J mice, we next attempted to determine whether signal transduction via the IL-12R complex was normal. Anti-CD3 induced blasts were incubated with IL-12, and whole cell lysates were subsequently incubated with a labeled GAS probe and analyzed by EMSA. Phosphorylated Stat4 homodimers can bind to this probe and retard its migration through a polyacrylamide gel. IL-12 induced a prominent band shift with extracts of blast cells from B10.Q/Ai mice, but not with extracts prepared from B10.Q/J mice, even when the extracts were from cells that initially were stimulated with IL-12 in addition to anti-CD3 (Fig. 8A) . This abnormality is not a manifestation of global cytokine signaling dysfunction, as generation of a CD23 promoter-binding element in response to IL-2 is completely normal in these mice (Fig. 8B) .
Stat4 phosphorylation in response to IL-12 is markedly impaired in B10.Q/J mice
One of the requirements for Stat4 homodimerization and subsequent binding to DNA is that it be phosphorylated (6) . To assess the ability of IL-12 to induce Stat4 phosphorylation in cells from B10.Q/J mice, Con A blasts were serum and cytokine starved for 18 h and then incubated with IL-12 for 5 or 15 min, which is generally adequate time to induce phosphorylation of Stat4. Lysates from cells thus treated were run out on SDS-PAGE and immunoblotted with an Ab specific for the phosphorylated form of Stat4. As can be seen in Fig. 9A , Stat4 phosphorylation was seen at 5 min in both the blots from the control human NK cell line, NK3.3, and B10.Q/Ai cells. No Stat4 phosphorylation was noted, even after 15 min, in the blots prepared from B10.Q/J cells, whereas lysates from the control animal cells show increased phosphorylation at the later time point. These differences are not due to different levels of Stat4, as the reblot in Fig. 9A (bottom) shows similar levels of protein expression.
As demonstrated in Fig. 4 and in the accompanying article (15) , describing the in vivo study of resistance of B10.Q/J mice to Toxoplasma gondii infection, under certain circumstances cells from IL-2 (B) . Cell extracts were then tested for the presence of DNA binding elements by EMSA.
B10.Q/J mice appear to be capable of responding to IL-12, suggesting that IL-12 can signal appropriately through the IL-12R complex. To further address this issue, we increased both the concentration of IL-12 and prolonged the incubation time in the Stat4 phosphorylation assays. Surprisingly, when B10.Q/J blasts were cultured with 50 ng/ml IL-12 for 50 min, Stat4 phosphorylation was induced (Fig. 9B) .
Discussion
Our data demonstrate that the subline of B10.Q mice maintained at The Jackson Laboratory manifests a spontaneous mutation that renders its T and NK cells unable to respond to IL-12. The function of other cell types that are capable of responding to IL-12, such as dendritic cells, may also be abnormal in this strain. Because IL-12 is required for Th1 differentiation, it is not surprising that we were unable to generate IFN-␥-producing Th1 cells by immunization of this strain with Ag in CFA. Furthermore, we were unable to induce CIA in this strain which expresses the susceptible MHC haplotype, H-2 q , whereas a subline of B10.Q that has been maintained separately at Taconic Farms is readily susceptible to CIA. In many respects, the B10.Q/J mouse resembles IL-12R␤1 Ϫ/Ϫ mice (9). NK cells and Con A-activated splenocytes from both strains fail to produce IFN-␥ when stimulated with IL-12, and activated T cells from both strains fail to proliferate when cultured with IL-12. However, T-depleted spleen cells from the B10.Q/J mice did produce low levels of IFN-␥ when stimulated with 50 ng/ml IL-12, whereas the IL-12R␤1 Ϫ/Ϫ mice did not respond to concentrations of IL-12 as high as 5000 ng/ml.
Although the B10.Q/J and IL-12R␤1 Ϫ/Ϫ mice share many phenotypic features, our studies using mAbs to both the IL-12R ␤1-and ␤2-chains clearly demonstrate that their expression on activated T cells and NK cells is indistinguishable from that of the B10.Q/Ai strain. Although mutations of the IFN-␥R have been described that result in failure of IFN-␥ to bind to its receptor in the presence of normal receptor expression (20) , similar mutations of the IL-12R complex in humans have not been reported. In any case, sequencing of both chains of IL-12R from the B10.Q/J and B10.Q/Ai strains has not revealed any differences; however, there appears to be significant polymorphism in the extracellular domain of the IL-12R ␤1-chain among several of the strains examined (D. Frucht and J. O'Shea, unpublished observations).
We also considered that the defect in the B10.Q/J strain was a mutation in the Stat4 that is responsible for IL-12-mediated gene activation. However, normal levels of Stat4 were present in B10.Q/J mice, and we were able to induce phosphorylation of Stat4 with high concentration of IL-12 and prolonged incubation times. In any case, the complementation studies in the accompanying paper (15) demonstrate that Stat4 function in the B10.Q/J strain is completely normal. Collectively, the lack of genetic defects in Stat4 or both chains of the IL-12R complex with major defects in Stat4 phosphorylation in response to IL-12 strongly point to defects in the only two known upstream components of this pathway, the Jak kinases, Tyk2 and Jak2. It is unlikely that the defect is at the level of Jak2 given that this kinase is critically important for signaling by other cytokine receptors including IFNs and hemopoietic growth factors (21, 22) . Jak2-deficient mice also show embryonic lethality due to the absence of erythropoiesis. It remains possible that the mutation in the B10.Q/J mouse might be in an adapter protein that specifically couples the IL-12R, but not other cytokine receptors, to Jak2.
We have attempted to analyze Tyk2 phosphorylation in response to IL-12 and determine whether differences exist between the B10.Q/J and B10.Q/Ai strains. However, we have been unable to detect specific phosphorylation of Tyk2 in either strain using Con A T blasts and the reagents that are presently commercially available. Very recently, two groups have generated Tyk2-deficient mice (23, 24) . There are several features in common between the Tyk2 Ϫ/Ϫ mice and the B10.Q/J mice, but several subtle differences are also present. Stat4 phosphorylation was detectable in blast cells from Tyk2 Ϫ/Ϫ mice at 15 min but was quantitatively lower than the level of phosphorylation seen in the wild type. In contrast, B10.Q/J mice had absolutely no detectable phosphorylation at these time points at the concentrations of IL-12 tested but did manifest similar low levels of Stat4 phosphorylation after prolonged exposure to a higher concentration of IL-12. It appears as if the loss of Tyk2 results in a dampening effect, whereas the defect in the B10.Q/J strain seems to have a delaying effect on Stat4 phosphorylation. T cell blasts from B10.Q mice failed to specifically proliferate when stimulated with IL-12, whereas T cells blasts from the Tyk2 Ϫ/Ϫ mice, the capacity of B10.Q/J mice to respond to LPS by activation of NO production was normal (G. Yap, unpublished observations). Resolution of these differences will require more detailed studies of Tyk2 function in the B10.Q/J strain, sequencing of the Tyk2 genes in both strains, as well as breeding Tyk2 Ϫ/Ϫ mice to B10.Q/J mice.
One important finding in our in vitro experiments was the ability of IL-18 to partially reconstitute the capacity of T-depleted spleen cells containing NK cells to respond to IL-12 by producing IFN-␥ after 72 h of culture. In contrast, activated T cell blasts failed to produce IFN-␥ when similarly stimulated. One possibility is that at the level of the NK cell, IL-18 modulates the expression of multiple other signaling pathways that augment the low levels of IL-12-mediated Stat4 signaling. As will be demonstrated in the accompanying report, in vivo treatment of B10.Q mice with IL-18 had profound effects on enhancing their resistance to infection with T. gondii by an IL-12-dependent mechanism. If the defect in the B10.Q/J mice is at the level of a subtle mutation in Jak2 or Tyk2, it is possible that the defective function of these kinases may be overridden by excess IL-18.
Studies of mice with selective deficiencies of components of the Th1 cytokine pathway have strongly supported the critical role of Stat4 in IL-12 responsiveness and Th1 differentiation. However, recent observations with lymphocytes from patients with increased susceptibility to atypical mycobacteria and Salmonella infections have raised the possibility that IL-12-mediated activation of other Stats may also be needed to generate a Th1 response of sufficient potency to eradicate intracellular infections. Thus, Gollob et al. (7) have recently described a patient with Mycobacterium avium infection and recurrent Staphylococcus aureus sinusitis whose cells resembled the B10.Q/J mouse, in that they expressed normal levels of the IL-12R ␤1-and ␤2-chains but, in contrast to the B10.Q/J mouse, phosphorylated Stat4 normally in response to IL-12. However, the activation of Stat1, -3, and -5 by IL-12 was completely absent. These results emphasize the complexity of the IL-12-mediated Th1 differentiation pathways. The availability of an inbred strain of animals, such as the B10.Q/J mouse, with a defect in IL-12 responsiveness should be a valuable resource in analyzing the complexity of IL-12-mediated signal transduction.
